Roche 6800 ctng
WebApr 16, 2024 · NEW YORK (GenomeWeb) – Roche said today that the US Food and Drug Administration has provided 510(k) clearance for its Cobas CT/NG assay for use on its … WebThe simple path to accuracy. CT and NG multiplex assay with flexible order capability. A qualitative multiplex assay that simultaneously detects two CT independent DNA targets …
Roche 6800 ctng
Did you know?
WebApr 16, 2024 · Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for cobas® CT/NG for use on the cobas® 6800/8800 WebThe Abbott RealTi m e CT/NG assay is an in vitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA of Chlamydia trachomatis and the genomic DNA of Neisseria gonorrhoeae. The assay may be used to test the following specimens from symptomatic individuals: female endocervical swab, clinician-collected ...
Webcobas CTNG for use on cobas 6800/8800 systems: Applicant: Roche Molecular Systems, Inc. 4300 Hacienda Drive: ... Aradhana Karthikeyan: Correspondent: Roche Molecular … WebJan 25, 2024 · In the field of sexually transmitted disease (STD), Roche and Hologic provide assays for diagnosing Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV). A total of 212 clinical samples were tested.
WebComparison between Aptima® assays (Hologic) and the CoBAS® 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium Nowadays, it is of utmost importance to use fully validated assays for molecular-based diagnosis. WebEfficiency and standardization with full laboratory automation. The cobas® 6800 System and cobas® 8800 System provide up to 96 results in about 3 hours and, from an eight …
WebDec 22, 2016 · „Die Hinzunahme von cobas® CT/NG zu unserem expandierenden Angebot für die Systeme cobas® 6800/8800 gibt Labors die Lösung für Tests auf CT/NG mit dem höchsten Durchsatz auf dem Markt an die...
demon anisearchWebApr 16, 2024 · Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems - First moderate complexity molecular test for sexually transmitted infections on … demon antonymWebcobas ® CT/NG for use on the cobas ® 6800/8800 Systems is an automated, qualitative in vitro nucleic acid diagnostic test, that utilizes real-time polymerase chain reaction (PCR), … ff14 how to blacksmithWebThe Cobas 6800/8800 provides fully automated sample preparation with real-time polymerase chain reaction (PCR) based NAAT technology for amplification and detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG). Single (CT) and dual (CTNG) testing services are available. ff14 how to become red mageWebRoche Molecular Systems, Inc. Nobuko Nakajima Manager, Regulatory Affairs 4300 Hacienda Drive Pleasanton, California 94588-2722 ... CT/NG on cobas® 6800/8800 Systems or the cobas® CT/NG v2.0 Test. Type of Use (Select one or both, as applicable) Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) ... ff14 how to be scholarWebDec 22, 2016 · Roche lance le test cobas® CT/NG sur les systèmes cobas® 6800/8800 dans les marchés acceptant le marquage CE /PRNewswire/ -- Roche (SIX : RO, ROG; OTCQX : RHHBY) a annoncé aujourd'hui le... ff14 how to blacklistWebDec 23, 2016 · Roche has launched CT/NG on the cobas 6800/8800 Systems in markets accepting the CE mark. The systems are intended for the direct identification of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) DNA in individuals with symptoms. demon and jesus